Fact 4: A Gendered Prevalence
Peeling through the demographics of BMS reveals a curious trend – the condition displays a significant gender bias. Women, particularly those who have entered the postmenopausal phase, are disproportionately affected. But why does BMS display such a preference?
Hormonal fluctuations are believed to play a key role. The postmenopausal phase is characterized by a sharp decline in estrogen levels. Estrogen has several functions in the body, and its role in maintaining oral health is now becoming clearer. Some theories suggest that reduced estrogen levels can impact the oral mucosa’s nerve fibers, potentially triggering BMS symptoms.
However, it’s not just postmenopausal women who are affected. BMS can also strike women during other phases characterized by hormonal shifts, such as menstruation or pregnancy. This recurrent theme of hormonal changes cements the theory that hormones, especially estrogen, have a pivotal role in the onset and progression of BMS.
However, while the gendered prevalence is evident, it’s essential to note that men are not immune. They, too, can develop BMS, albeit in fewer numbers. The underlying causes in men are less understood and require further research.
From a treatment standpoint, this gendered prevalence can guide therapeutic interventions. For some women, hormone replacement therapy (HRT) has proven beneficial in alleviating BMS symptoms. However, HRT isn’t suitable for everyone and comes with its own set of risks, so a thorough evaluation is imperative before embarking on such treatments. (4)
